Physician
Haider Afzal MD PA
Haider Afzal MD PA was paid $1.91M by Medicaid between Jan 2018 and Dec 2024, across 98 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoHAIDER AFZAL MD PA
BAYTOWN, TX 77521
BAYTOWN, TX 77521
33aNPI1699003053assigned 11/24/2009
33bProvider typeFamily Medicine Physician
28Total paid$1.91M
24GClaims67,348
24DCodes billed98
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#59 of 1,204
Median peer was paid$31K
This provider vs. median62×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,076 | $64K | |
| 2019 | 1,522 | $25K | |
| 2020 | 7,628 | $194K | |
| 2021 | 18,395 | $445K | |
| 2022 | 14,423 | $382K | |
| 2023 | 13,262 | $385K | |
| 2024incomplete | 10,042 | $413K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 12,750 | 10,033 | $549K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 20% | 8,841 | 1,355 | $391K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 8,634 | 6,968 | $259K |
| 99223 | Prolong inpt eval add15 m | 5.2% | 1,053 | 985 | $99K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.7% | 3,980 | 3,148 | $89K |
| 99444 | 3.9% | 1,450 | 345 | $74K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.1% | 756 | 730 | $40K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 2,903 | 2,291 | $35K |
| 96130 | 1.5% | 527 | 474 | $28K | |
| 99423 | 1.5% | 568 | 141 | $28K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 322 | 297 | $27K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 333 | 315 | $27K |
86 more codes
| 36410 | 1.4% | 2,221 | $26K | |
| 86769 | 1.1% | 392 | $22K | |
| 86328 | <1% | 341 | $17K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 215 | $16K |
| 81025 | <1% | 2,391 | $16K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,108 | $13K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 185 | $13K |
| 81002 | <1% | 4,315 | $11K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 152 | $11K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 102 | $11K |
| 93880 | <1% | 96 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 197 | $9K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 215 | $8K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 94 | $8K |
| 93000 | <1% | 750 | $8K | |
| 95816 | <1% | 45 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 159 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 420 | $5K |
| 99385 | <1% | 64 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 39 | $4K |
| 81003 | <1% | 1,898 | $3K | |
| 0001A | <1% | 69 | $3K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 142 | $2K |
| 99384 | <1% | 34 | $2K | |
| 95957 | <1% | 43 | $2K | |
| 0002A | <1% | 48 | $2K | |
| 99490 | Ccm add 20min | <1% | 975 | $2K |
| 99000 | <1% | 244 | $2K | |
| 99001 | <1% | 484 | $2K | |
| 90461 | <1% | 223 | $2K | |
| S9470 | Nutritional counseling, dietitian visit | <1% | 29 | $2K |
| 92585 | <1% | 38 | $1K | |
| 0011A | <1% | 62 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 58 | $1K |
| 0012A | <1% | 34 | $1K | |
| 95943 | <1% | 18 | $1K | |
| 95923 | <1% | 17 | $1K | |
| 95930 | <1% | 40 | $1K | |
| 96132 | <1% | 41 | $937.17 | |
| 95886 | <1% | 15 | $823.59 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 93 | $736.21 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 601 | $581.02 |
| 90658 | <1% | 43 | $534.66 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 62 | $449.90 |
| 93923 | <1% | 26 | $404.16 | |
| 92551 | <1% | 159 | $348.38 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 59 | $310.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 46 | $281.95 |
| 93040 | <1% | 61 | $260.50 | |
| 99439 | <1% | 15 | $223.55 | |
| 96103 | <1% | 49 | $180.42 | |
| 96160 | <1% | 123 | $179.19 | |
| 94010 | <1% | 12 | $169.06 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 340 | $168.18 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 56 | $160.69 |
| 99072 | <1% | 281 | $156.00 | |
| 90734 | <1% | 65 | $140.00 | |
| 87400 | <1% | 44 | $130.57 | |
| 90715 | <1% | 43 | $107.10 | |
| 90686 | <1% | 58 | $37.82 | |
| 90670 | <1% | 129 | $36.00 | |
| 36416 | <1% | 801 | $5.25 | |
| 96127 | <1% | 613 | $4.87 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 484 | $0.18 |
| 82962 | 0% | 289 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 813 | $0.00 |
| 90688 | 0% | 28 | $0.00 | |
| 3074F | 0% | 67 | $0.00 | |
| 96139 | 0% | 41 | $0.00 | |
| 93922 | 0% | 20 | $0.00 | |
| 90680 | 0% | 13 | $0.00 | |
| 90647 | 0% | 12 | $0.00 | |
| 90660 | 0% | 14 | $0.00 | |
| 90716 | 0% | 14 | $0.00 | |
| 90713 | 0% | 15 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 12 | $0.00 |
| 99173 | 0% | 322 | $0.00 | |
| 96138 | 0% | 39 | $0.00 | |
| 90633 | 0% | 78 | $0.00 | |
| 90649 | 0% | 44 | $0.00 | |
| 90710 | 0% | 51 | $0.00 | |
| 90653 | 0% | 13 | $0.00 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 0% | 18 | $0.00 |
| 90707 | 0% | 17 | $0.00 | |
| 90700 | 0% | 22 | $0.00 | |
| 92546 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAFZAL, HAIDER (OWNER)